... effective than the PPIs. 13C-urea breath test Peptic ulcer Proton pump inhibitor Lifestyle Potassium-competitive acid blocker 20 02 2018 12 06 2018 4 09 2018 © 2018 S. Karger AG, Basel Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

...Yaron Niv; Doron Boltin The incidence of Helicobacter pylori and non-steroidal anti-inflammatory drug (NSAID)-negative peptic ulcer disease has increased over the last two decades, especially in the Western world and in countries with low H. pylori infection rates. Idiopathic peptic ulcer disease...

... mellitus Gastric ulcer Leptin Ob-R Peptic ulcer Stomach Ulcer healing Vascular endothelial growth factor Gastric ulcer was induced by a method described in detail elsewhere[ 22 ], with minor modifications. In brief, under ether anesthesia, the abdomen was incised and the stomach...

... from any ideas, methods, instructions or products referred to in the content or advertisements. 1997 Sucralfate Intestinal mucosa Cell culture Restitution Adhesion Peptic ulcer Caco-2 Digestion Original Paper Digestion 1997:58:34-42 Nancy J. Emenaker Sandeep Datla Marc D. Basson...

.... Hydrogen ion diffusion Mucus Ammonium bicarbonate Peptic ulcer Helicobαcter pylori Original Paper Digestion 1993:54:32-39 M.A. Desai P.M. Vadgama Department of Medicine (Clinical Biochemistry), University of Manchester, Hope Hospital, Salford, UK Enhanced H+Diffusion by NH^/HCOi...

.... Helicobacter pylori 14C-Urea breath test Peptic ulcer Digestion 1991:50:16-21...

... concentrations, and that this response is independent of luminal pH. Peptic ulcer Gastrins Original Paper Digestion 1992;52:173-178 Steven F. Mossa Raymond J. Playforda Kwabe Ayesua S .K .L ib John Calama a Gastroenterology Unit and b Department of Surgery, Royal Postgraduate Medical School, Hammersmith...

.... In patients with H. pylori-τeiated antral or pangastritis, peptic ulcer disease, and in particular duodenal ulcer, is common (with an incidence exceeding 20% after 10 years’ follow-up), as compared with peptic ulcer disease, which is very rare in patients with a normal stomach. Gastric ulcer may sometimes...

... Omeprazole Gastrin Hypergastrinaemia Gastritis Enterochromaffin-like cells Argyrophil cells Hyperplasia Peptic ulcer Digestion 1992;51(suppl 1):76 81 W. Creutzfeldt R. Lamberts Division of Gastroenterology anti Endocrinology, Department of Medicine, Georg-August University of Göttingen, Gottingen...

... years of continuous treatment with omeprazole. Omeprazole Drug safety Gastric mucosa Neoplasia Peptic ulcer Multiple endocrine neoplasia Carcinoid tumours Hyperplasia Enterochromaffin-like cells Digestion 1992;51(suppl 1): 115 119 R. McCloy University Department of Surgery, Manchester...

...G.H.G. Brunner; C. Thiesemann The efficacy of intravenous omeprazole has been investigated in a number of clinical applications. In critically ill patients with bleeding peptic ulcer, which developed despite prophylactic measures for stress ulcer, bleeding stopped in 16 out of 19 patients treated...

...E. Jiménez; F. Bosch; J.L. Galmés; J.E. Baños Zinc acexamate (ZAC) is a new drug for the treatment of peptic ulcer. The present study was performed in order to evaluate the clinical efficacy of ZAC in peptic ulcer, using a meta-analysis of all randomized clinical trials performed with this drug...

... inflammation in all patients in at least one site. After 8 weeks during which indomethacin therapy was continued, a further endoscopy revealed lesions in 5 patients – peptic ulcer in 3 and erosions in 2 – but only 1 of these had any change in gastro-intestinal symptoms. Irrespective of whether mucosal lesions...

...G.H.G. Brunner; R. Lamberts; W. Creutzfeldt A total of 143 patients with peptic ulceration of the duodenum, stomach and oesophagus who did not respond to 3 or more months of high-dose treatment with ranitidine, 450 mg or more daily, were treated with oral omeprazole, 40 mg daily. In 94...

.... 1990 G cell hyperfunction Gastrin Peptic ulcer Tripotassium dicitrato bismuthate Digestion 1990;46:65-71 © 1990 S. Karger AG, Basel 0012-2823/90/0462-0065S2.75/0 Medical Treatment of Antral Gastrin Cell Hyperfunction: Role of Nonantisecretory Therapy G. Delle Fave, B. Annibale, M. Puoii, E...

... of each NSAID used against 15 isolates of Campylobacter pylori were also determined. Campylobacter-like organisms Campylobacter pylori Chronic gastritis Peptic ulcer Nonsteroidal anti-inflammatory drugs Rheumatoid arthritis Digestion 1989:44:101-104 © 1989 S. Karger AG. Basel 0 0 12 - 2 8 2 3...

...A.L. Blum Arguments in favour of the use of omeprazole outweigh the arguments against its use in the treatment of all peptic disorders – duodenal ulcer, gastric ulcer and reflux oesophagitis. Omeprazole Peptic ulcer Reflux oesophagitis Digestion 1989;44(suppl I):87 91 © 1989 S. Kargcr AG...

..., instructions or products referred to in the content or advertisements. 1989 Omeprazole H2-receptor antagonists Peptic ulcer Duodenal ulcer Gastric ulcer Prepyloric ulcer Healing rate Pain relief Non-steroidal anti-inflammatory drugs Digestion 1989;44(suppl I):25 30 © 1989 S. Karger AG. Basel...

... methylated PGE 2 was completely ineffective in this model. Non-colloidal bismuth subnitrate, in contrast to CBS, was ineffective against stress-induced lesions. CBS stimulated mucosal generation and luminal release of PGE 2 dose dependently. Colloidal bismuth subcitrate Gastroprotection Peptic ulcer...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 1988 Mucosal growth Peptic ulcer Growth hormone-releasing factor...